Wistar Institute spinout company Virion Therapeutics raised a $4 million angel round, according to an SEC filing.

The immunotherapy company is working on a path to commercialization for a set of vaccines aimed at treating certain types of cancers and chronic viral infections.

Cofounded by Wistar Institute professor Hildegund C.J. Ertl, Andrew Luber and Bernie Rudnick, the company is working on scientific assets that have been backed by some $25 million in grants.

The Philly-based company will use the funds to complete an FDAInvestigational New Drug (IND) filing for its lead HPV vaccine candidate, and perform preclinical work on another vaccine for chronic HBV infection.

READ FULL ARTICLE HERE